SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : ASK: "THE LAST DON" OF MOMENTUM TRADES -- Ignore unavailable to you. Want to Upgrade?


To: Charles Broderick who wrote (4844)1/29/1999 7:06:00 AM
From: Manfred  Respond to of 15987
 
PFE: fda panel backs heart drug (Tikosyn). Looks like another 400 mil annual rev for Pfizer. This company is the best pharma comp out there.

biz.yahoo.com

+ split news
+ viagra approved in Japan

--->> Everyone and esp. the larger funds will want PFE. It will run big time the next weeks ahead. My very short term target is 140+.

Manfred



To: Charles Broderick who wrote (4844)1/29/1999 7:56:00 AM
From: Stockbull  Read Replies (1) | Respond to of 15987
 
I'm still positive on JNNE,it's not over by a long shot,IMHO.

Today----CELN---- should be interesting...